Shanghai Kaibao Pharmaceutical Co., Ltd.
Release time:
2022-01-19
The Phlegm-Heat Clearing Injection developed and produced by Shanghai Kaibao Pharmaceutical Co., Ltd. has successively won several honors, including the "National Modern Traditional Chinese Medicine High-Tech Industrialization Demonstration Project" from the National Development and Reform Commission; key new product for combating SARS in Shanghai; "Shanghai Excellent Products in the Pharmaceutical Industry"; Shanghai High-Tech Achievement (A) Level Transformation Project; National Science and Technology Innovation Fund Support Project; Third Prize for Scientific and Technological Progress in Shanghai; "Influenza Prevention and Treatment Traditional Chinese Medicine Reserve Directory" from the National Development and Reform Commission; "Influenza Prevention and Treatment Reserve Drugs"; Shanghai Brand Product; Shanghai Patent New Product; Top 100 Projects for Transformation of High-Tech Achievements in Shanghai and Top Ten Independent Innovation Projects; "Shanghai Famous Brand Product"; listed by the Ministry of Health as a medication for the "Avian Influenza Diagnosis and Treatment Plan"; and in 2009, designated by the Ministry of Health and the State Administration of Traditional Chinese Medicine as a clinical designated medication in the "Clinical Technical Guidelines for Traditional Chinese Medicine in the Prevention and Treatment of Hand, Foot, and Mouth Disease" and the "H1N1 Influenza Diagnosis and Treatment Plan (2009 Trial Version 2nd Edition)". The Phlegm-Heat Clearing Injection has gained wide recognition from doctors and patients, becoming a well-known product brand, and its market performance is leading among similar products.
To accelerate development, Kaibao Pharmaceutical built a new factory in the Shanghai Industrial Comprehensive Development Zone in 2008, with a total investment of 300 million yuan. In the same year, the retail sales of Kaibao Pharmaceutical's Phlegm-Heat Clearing Injection reached 453 million yuan in hospitals.
The Phlegm-Heat Clearing Injection developed and produced by Shanghai Kaibao Pharmaceutical Co., Ltd. has successively won honors such as the "National Modern Traditional Chinese Medicine High-Tech Industrialization Demonstration Project" from the National Development and Reform Commission; key new products for Shanghai's fight against SARS; "Shanghai's Famous and Excellent Pharmaceutical Products"; Shanghai's A-level high-tech achievement transformation project; National Science and Technology Innovation Fund support project; Third Prize for Scientific and Technological Progress in Shanghai; included in the "Influenza Prevention and Treatment Traditional Chinese Medicine Reserve Catalog" by the National Development and Reform Commission; Shanghai brand products; Shanghai patent new products; one of the top 100 projects for the transformation of high-tech achievements in Shanghai and one of the top ten projects for independent innovation; "Shanghai Famous Brand Products"; listed by the Ministry of Health as a medication for the "Avian Influenza Diagnosis and Treatment Plan"; in 2009, it was designated as a clinical medication in the "Clinical Technical Guidelines for Traditional Chinese Medicine in the Prevention and Treatment of Hand, Foot, and Mouth Disease" and the "A/H1N1 Influenza Diagnosis and Treatment Plan (2009 Trial Version 2nd Edition)" by the Ministry of Health and the State Administration of Traditional Chinese Medicine. The Phlegm-Heat Clearing Injection has gained wide recognition from doctors and patients, becoming a well-known product brand, with market performance leading among similar products.
Shanghai Kaibao Pharmaceutical Co., Ltd. was established on April 12, 2000, and was renamed Shanghai Kaibao Pharmaceutical Co., Ltd. on September 8, 2008, after restructuring. The company has invested over 100 million yuan in new product development and production technology transformation, continuously introducing various professional technical personnel, expanding the production scale from one production workshop to the current four production workshops (solid preparations, oral liquid preparations, small volume injections, and traditional Chinese medicine extraction), and has successively passed the national GMP certification. The company's economic indicators have been rising year after year, growing from a taxable sales revenue of over 3 million yuan in 2001 to 450 million yuan in 2008, a 100-fold increase over eight years.
In 2008, the sales revenue reached 450 million yuan, with total tax payments of 78.88 million yuan, achieving a continuous 50% high-speed growth in sales revenue for three consecutive years.
Over the years, Kaibao Pharmaceutical has cultivated a distinctive corporate culture: "Talent as the foundation, quality as the center, dedication and pragmatism, daring to be the first in the world." With this intangible belief guiding the company, Kaibao Pharmaceutical has maintained a steady development trend. Over eight years, the Phlegm-Heat Clearing Injection, which has invested over 100 million yuan since its production began in 2003, has gained wide recognition from doctors and patients, becoming a well-known product brand, with market performance leading among similar products. The culture of Kaibao Pharmaceutical has evolved from its birth, development, to maturity and upgrading, which is also a process where corporate culture and corporate competitiveness complement and enhance each other.
Creating a culture of creativity means leveraging human initiative and creativity in every aspect, including product selection, quality shaping, brand building, and hospital services, to achieve differentiation through innovation, grasp market trends, and ensure market leadership. In developing the company's flagship modern traditional Chinese medicine Phlegm-Heat Clearing Injection, the company creatively adopted the principle of "determining effective components based on symptoms and prescriptions," and was the first to use fingerprinting technology in the field of traditional Chinese medicine injections, aiming to maximize the purification of effective medicinal components and remove impurities during the manufacturing process to ensure product safety.
Building corporate execution capability ultimately leads the team to form an execution culture that emphasizes reality, clear goals, simplicity and efficiency, strong supervision, unity, tension, seriousness, and liveliness. "In-depth and meticulous ideological and political work, strong administrative support" is its management principle. A clear system of rewards and punishments, along with strong guarantees, has created a "semi-militarized" management atmosphere in the company, ensuring that good strategies are implemented in every detail of execution.
Emphasizing learning ability means advocating for a learning-oriented team, learning from excellent companies, books, customers, and the market. Kaibao Pharmaceutical always regards talent as the foundation of the company's development, sending senior management personnel to participate in a series of MBA training courses every year to improve management levels and enhance knowledge structure. At the same time, the company invests a large amount of money each year to invite well-known training companies in the industry to provide various training for all marketing personnel, and the sales headquarters has also invested 500,000 yuan to establish a training center. In the past three years, the per capita training cost of the company has exceeded 2,000 yuan. Professional training not only insists on being long-term and inclusive but also emphasizes the quantification of training evaluation effects, meaning that whether for management personnel, professional technical personnel, or marketing personnel, they must undergo training assessments, and the assessment results are directly linked to individual benefits. Training provides strong support for the overall improvement of employee quality and guarantees the enhancement of Kaibao Pharmaceutical's core competitiveness.
Related Information
Beijing XinyiHuida Electromechanical
E-mail: xinyihuida@163.com
Mobile: +86-13911770565 Mr. Lin (General Manager)
Address: 415, 4th Floor, No.2 Jinguangnan Street, Jinguangnan Street, Xilu Street, Fangshan District, Beijing
Product Category
Copyright© Beijing XinyiHuida Electromechanical Equipment Co., Ltd